TOP2A protein by quantitative immunofluorescence as a predictor of response to epirubicin in the neoadjuvant treatment of breast cancer
Moretti, Erica, Desmedt, Christine, Biagioni, Chiara, Regan, Meredith M, Oakman, Catherine, Larsimont, Denis, Galardi, Francesca, Piccart-Gebhart, Martine, Sotiriou, Christos, Rimm, David L, Di Leo, AVolume:
9
Language:
english
Journal:
Future Oncology
DOI:
10.2217/fon.13.103
Date:
October, 2013
File:
PDF, 1.25 MB
english, 2013